Press Releases

Gary tells his story about the difficult journey back to the slopes of Mt. Hood after receiving life-saving surgery for pancreatic cancer.

This is an exciting new trial comparing robotic assisted laparoscopy to open hysterectomy and lymph node assessment for the treatment of early-stage cervical cancer.

Providence has announced a streamlined executive leadership structure to better support its hospitals, advance strategic priorities and realize the vision of Health for a Better World.

The Truveta Genome Project will enable scientists to transform how diseases are prevented, diagnosed and cured.

Health care venture capital firm Allumia Ventures has spun off from Providence to become an independent venture capital firm following a first close of its third fund.

Providence announced plans to sell 10 skilled nursing and assisted living care ministries. The sale will ensure continued access to these vital services in its communities.

Catch the 2024 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.

Discover how Dean Lookingbill’s battle with lymphoma led him to CAR T-cell therapy at Providence Cancer Institute.

Providence announced results for the three months ended September 30, 2024. The not-for-profit health system continued to improve performance while serving more people in need.

Two global studies open at Providence Cancer Institute will evaluate combinations of medications to help stop or slow the growth of cancer in solid tumors.

Providence selects Darryl A. Elmouchi, M.D., MBA, as its new chief operating officer, effective Jan. 2.

Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice